Popular Posts

Wednesday, 15 November 2017

Hikma acquires six products from Boehringer for €3 million




Hikma Pharmaceuticals PLC (Hikma) has acquired six products from Boehringer Ingelheim GmbH (Boehringer Ingelheim), for an aggregate consideration of €3 million.
Boehringer Ingelheim is a related party of Hikma for the purposes of the UKLA Listing Rules (LRs) by virtue of its 17 percent shareholding in Hikma.

No comments:

Post a Comment